Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Advanced Life Sciences Gets $32M In Lethargic IPO Market

Aug. 8, 2005

By Jennifer Boggs

Advanced Life Sciences Gets $32M In Lethargic IPO Market

Aug. 8, 2005

By Jennifer Boggs

Par Dropping Advancis Deal After Amoxicillin Pulsys Miss

Aug. 5, 2005

By Jennifer Boggs

Par Dropping Advancis Deal After Amoxicillin Pulsys Miss

Aug. 5, 2005

By Jennifer Boggs

Autologous Cells Company Tengion Closes $39M Series A

Aug. 4, 2005

By Jennifer Boggs

Eximias' Thymitaq Misses In Phase III Liver Cancer Trial

Aug. 4, 2005

By Jennifer Boggs

Eximias' Thymitaq Misses In Phase III Liver Cancer Trial

Aug. 4, 2005

By Jennifer Boggs

Autologous Cells Company Tengion Closes $39M Series A

Aug. 4, 2005

By Jennifer Boggs

Alnylam's IP Portfolio Gains Traction As 'One-Stop Shop'

Aug. 3, 2005

By Jennifer Boggs

Alnylam's IP Portfolio Gains Traction As 'One-Stop Shop'

Aug. 3, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...